HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 24, No. 07, July 2020 – Mitigating the Impact of COVID-19: How is Food Security Threatened?       » COVID-19 vaccine Reaches Phase I Clinical Trial       » Mathematical Model to Define Eruptive Stages of Young Volcanic Rocks       » Artificial Intelligence to Tackle Agricultural Challenges       » Installation of Mobile X-Ray System at COVID-19 Screening Center in Korea       » World's First Spherical Artificial Eye      
EYE ON CHINA
BGI Partners with NRGene to Provide Broadest Genomic Analysis Available

Ness Ziona, Israel, and Shenzhen, China, August 15, 2016 – BGI, the world’s largest omics organisation, announced today that it will be offering NRGene’s technology as part of its broad genomics analysis services in agriculture research.

BGI supports genomic research worldwide by offering a variety of genetic research and application technologies for the healthcare, agriculture, conservation, and environmental fields. It also publishes the respected international research journal, GigaScience, to further contribute to the genomics community.

NRGene provides genomic assessment and assembly tools that solve the most complex genomic challenges accurately and rapidly. Most recently, NRGene mapped the bread and pasta wheat genomes, which represent the most complex genomes to assemble, in mere weeks rather than years.

“We have recognised the complementary capabilities that NRGene’s and BGI’s technologies provide to the Chinese genomics community, with its wide and diverse challenges,” said Gao Qiang, CEO of BGI Tech. “The combined technologies will transform Asian agriculture.”

NRGene’s DeNovoMAGICTM 2.0 delivers the most accurate reference genomes fast and cost effectively, while PanMAGICTM provides genome-to-genome mapping across varieties. It displays all types of sequence differences and structural variations within the studied genetic material including SNPs, InDels of any size, inversions, translocations, gene PAVs, and gene CNVs.

“Being a selected technology by the world’s leading omics group is a major step forward as we continue to disrupt the genomics industry,” said Dr. Gil Ronen, CEO, NRGene. “Our high quality genomic analysis is already advancing agricultural genomics, and this will help drive us into other markets that are primed to accelerate their research.”

Source: NRGene & K2 Global Comms

Click here for the complete issue.

NEWS CRUNCH  
news Proteona Honoured with "one to watch" Prize in the Inaugural Spinoff Prize by Nature Research and Merck Group
news Twist Bioscience and Proteona Join Hands to Protect Immunocompromised Patients from COVID-19 Infection
news Innovation in Healthcare: IOT-Enabled Tele-Ventilators to Fight Against the COVID-19 Pandemic
news Proteona leads international consortium to develop SARS-CoV-2 neutralizing antibody to help vulnerable immunocompromised individuals
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2020 World Scientific Publishing Co Pte Ltd  •  Privacy Policy